Institut Jules Bordet is a specialized general hospital and research institute of the Université libre de Bruxelles which specializes in oncology. It is located in Brussels, Belgium.

During the past decade, Institut Jules Bordet - Oncologie Médicale conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Jules Bordet - Oncologie Médicale" #1 sponsor was "BeiGene" with 1 trials, followed by "Clavis Pharma" with 1 trials sponsored, "Epizyme, Inc." with 1 trials sponsored, "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored and "SOTIO a.s." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Institut Jules Bordet - Oncologie Médicale" are "Advanced Adenocarcinoma of Pancreas" (1 trials), "Any Solid Tumor With an EZH2 GOF Mutation" (1 trials), "Atypical Teratoid Rhabdoid Tumors (ATRT)" (1 trials), "Bone Metastases" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Institut Jules Bordet - Oncologie Médicale" in a lesser frequency.

Most popular intervention types in "Institut Jules Bordet - Oncologie Médicale" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials), "DCVAC/PCa" (1 trials) and "EMD 525797" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Jules Bordet - Oncologie Médicale" are 4 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Jules Bordet - Oncologie Médicale". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Institut Jules Bordet - Oncologie Médicale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Jules Bordet - Oncologie Médicale, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".